March 23. DOI: 10.1093/ofid/ofaa105. 5 Wu C, Chen X, Cai Y, et al. Risk factors associated
with acute respiratory distress syndrome and death in patients with coronavirus disease …

Dear Editor, We read with great interest the letter by Cumhur Cure M et al., who raised
several points of concern about the use of colchicine for the treatment of severe acute …

Introduction SARS-CoV-2 pneumonia is often associated with hyper-inflammation. The
cytokine-storm-like is one of the targets of current therapies for coronavirus disease 2019 …

14: 321. by two members of the numb associated kinase family is one of the many unfamiliar
effects of a relatively recent drug class, the real safety profile of which still remains to be …

Humoral and cell-mediated immune responses are blunted after SARS-CoV-2 vaccination in
patients with a history of CD20 B-cell-depleting treatment. 1 However, vaccination induces …

Introduction: While waiting for the development of specific antiviral therapies and vaccines to
effectively neutralize the SARS-CoV2, a relevant therapeutic strategy is to counteract the …

Vaccines against SARS-CoV-2 represent a pivotal and effective countermeasure to contain
the COVID-19 pandemic. Four vaccines are approved by the European Medicines Agency …

DEAR EDITOR, Severe Acute Respiratory Syndrome-CoronaVirus-2 (SARS-CoV-2)
infection disease (COVID-19) is a novel disease identified in a cluster of pneumonia in the …

Пандемия коронавирусной болезни 2019 (COVID-19) привлекла более пристальное,
чем прежде, внимание к проблемам иммунопатологии болезней человека, многие из …